Holen Sie sich die Stockscreener-App
15.78
2.83%
-0.46
Schlusskurs vom Vortag:
$16.24
Offen:
$16
24-Stunden-Volumen:
1.34M
Relative Volume:
1.09
Marktkapitalisierung:
$3.96B
Einnahmen:
$401.20M
Nettoeinkommen (Verlust:
$-283.01M
KGV:
-11.35
EPS:
-1.39
Netto-Cashflow:
$121.56M
1W Leistung:
-4.54%
1M Leistung:
-21.57%
6M Leistung:
-20.62%
1J Leistung:
+28.82%
1-Tages-Spanne:
$15.69
$16.16
1-Wochen-Bereich:
$15.69
$16.86
52-Wochen-Spanne:
$11.47
$26.30
Cellebrite Di Ltd Stock (CLBT) Company Profile
Firmenname
Cellebrite Di Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
15.78 | 3.96B | 401.20M | -283.01M | 121.56M | -1.39 |
|
MSFT
Microsoft Corporation
|
474.96 | 3.50T | 270.01B | 96.64B | 69.37B | 12.94 |
|
ORCL
Oracle Corp
|
215.22 | 487.99B | 57.40B | 12.44B | -394.00M | 4.34 |
|
PLTR
Palantir Technologies Inc
|
137.40 | 301.41B | 3.12B | 570.69M | 1.32B | 0.23 |
|
CRWD
Crowdstrike Holdings Inc
|
480.62 | 116.75B | 4.14B | -172.30M | 1.03B | -0.69 |
|
FTNT
Fortinet Inc
|
100.83 | 80.32B | 6.14B | 1.88B | 2.07B | 2.43 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Bestätigt | Needham | Buy |
| 2024-03-13 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2021-12-02 | Eingeleitet | BofA Securities | Buy |
| 2021-10-21 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Acquired by California State Teachers Retirement System - Defense World
Cellebrite to acquire Corellium for $170 million in cash, $20 million converted to equity at closing - MSN
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
Cellebrite DI (NASDAQ:CLBT) Receives Buy Rating from Needham & Company LLC - Defense World
Cellebrite DI to Acquire Corellium for $170M - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of “Buy” from Analysts - Defense World
Cellebrite DI Ltd. (CLBT) to Acquire Corellium - Insider Monkey
Cellebrite To Buy Corellium in $200M Deal - USA Herald
Cellebrite Strikes $200M Deal To Buy Testing Co. Corellium - Law360
Cellebrite DI Ltd. entered into an agreement to acquire Corellium, Inc. - marketscreener.com
Cellebrite (CLBT) Acquires Corellium for $170 Million, Expands O - GuruFocus
Cellebrite (CLBT) to Acquire Corellium in $170 Million Deal | CL - GuruFocus
Cellebrite to Acquire Corellium for $170 Million - TipRanks
Cellebrite DI to Acquire Corellium for $170 Million Enterprise Value - marketscreener.com
Cellebrite to Acquire Corellium - GlobeNewswire
Transcript : Cellebrite DI Ltd. Presents at Bank of America Global Technology Conference 2025, Jun-03-2025 10 - marketscreener.com
Cellebrite: Near-Term Growth Is A Key Concern (NASDAQ:CLBT) - Seeking Alpha
Nuveen Asset Management LLC Grows Position in Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
Here are Greenhaven Road Capital’s Views on Cellebrite (CLBT) - Insider Monkey
Bank of America Corp DE Increases Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
Northern Trust Corp Raises Stake in Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
Cellebrite Announces Participation in Upcoming Investor Conferences - GlobeNewswire
Cellebrite Lines Up 5 Wall Street Conferences: TD Cowen, BofA, William Blair Featured - Stock Titan
Needham & Company LLC Cuts Cellebrite DI (NASDAQ:CLBT) Price Target to $24.00 - Defense World
Cellebrite DI First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cellebrite’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates - MSN
Cellebrite DI (CLBT) Analyst Maintains Buy Rating Despite Lowered Price Target | CLBT Stock News - GuruFocus
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2025 Earnings Call Transcript - Insider Monkey
InvestingPro Fair Value model captures Cellebrite’s 35% downside potential By Investing.com - Investing.com Nigeria
Deutsche Bank Adjusts Cellebrite DI Price Target to $24 From $27, Maintains Buy Rating - marketscreener.com
Cellebrite DI (NASDAQ:CLBT) Shares Gap Down Following Weak Earnings - Defense World
Cellebrite Reports Strong Q1 2025 Financial Growth - TipRanks
Cellebrite Announces First-Quarter 2025 Results - GlobeNewswire
Dow Edges Higher; US Crude Oil Inventories Increase - Benzinga
Cellebrite (CLBT) Achieves 23% ARR Growth in Q1 amid Revenue Exp - GuruFocus
Cellebrite DI Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Cellebrite (CLBT) Beats Q1 EPS Estimates but Misses on Revenue - GuruFocus
Cellebrite Reports Robust Q1 2025 Financial Performance - TipRanks
Cellebrite Q1 Gross Margin 83.7% - marketscreener.com
Cellebrite DI Q1 Non-GAAP Earnings, Revenue Rise; Full-Year Sales Outlook Revised - marketscreener.com
JPMorgan Chase & Co. Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - Defense World
Cellebrite DI Ltd (CLBT) Q1 2025 Earnings Report Preview: What T - GuruFocus
JPMorgan Adjusts Cellebrite (CLBT) Price Target Amid Market Tren - GuruFocus
Cellebrite DI (CLBT) Price Target Lowered by JP Morgan | CLBT St - GuruFocus
Cellebrite DI (CLBT) to Release Earnings on Wednesday - Defense World
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of “Buy” by Analysts - Defense World
Cellebrite (CLBT) Unveils Spring 2025 Release with AI-Driven Innovations | CLBT Stock News - GuruFocus
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations - GlobeNewswire
Cellebrite's New AI Platform Slashes Digital Investigation Time from 69 Hours per Case - Stock Titan
Finanzdaten der Cellebrite Di Ltd-Aktie (CLBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.57%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):